Le Lézard
Classified in: Health, Covid-19 virus
Subject: PDT

World's First Zinc Ionophore Oral Spray Launches in the EU


MILAN, Aug. 1, 2020 /PRNewswire/ -- Dr ZinX has launched their Patent Pending Zinc + Hinokitiol Oral Spray across Amazon EU today. This is the first time a Zinc Ionophore oral spray combination has been available to the EU market.

"A combination of Zinc Salts and Hinokitiol can be applied as an inexpensive, effective and safe alternative approach to fight respiratory viruses." - Dr Nikola Kolundzic, Kings College London

Following wide publication and support from President Trump for the use of a Hydroxychloroquine + Zinc Combination, Zinc has come under increasing interest. Currently Hydroxychloroquine is only available through a prescription from a Doctor. This makes the launch of the Dr ZinX Oral Spray in the EU even more interesting given its status as a cosmetic, allowing doctors to issue it freely to patients, without need for a prescription.

Anti-Viral Role of Hinokitiol:

Hinokitol has been found to increase the cellular import of Zn2+ and to be effective in the combat with RNA viruses such as influenza virus, respiratory syncytial virus and picornaviruses. Hinokitiol is a tropolone compound with a seven-membered carbon ring and an isopropyl side chain. Zinc ion is of vital importance as a cofactor for various cellular processes and viral proteins. Metallothioneins regulate the intracellular concentration of free Zn2+. Intracellular Zn2+ concentration disrupts the replication cycle of certain RNA viruses. - MD MSci Marija Petkovic 

Role of Hinokitiol in Inflammation: 

Early evidence suggests that Hinokitiol has a role in dampening the immune response and preventing excessive inflammation. The culture of T lymphocytes generated from the spleen of mice resulted in reduced proliferation of lymphocytes and reduced expression of the inflammatory cytokine interferon gamma (IFN-?) which has a strong role in inflammatory diseases and autoimmunity. It has also shown that it up-regulates p21, a regulatory cell cycle inhibitor. The inhibition of this molecule results in malignant proliferation of T lymphocytes and autoimmunity. 

For Press Inquiries Contact: marketing@astivita.com.au

Related Files

Dr ZinX Infographic 2.jpg

Dr ZinX Patent Infographic.jpg

Related Images

dr-zinx-patent-pending.jpg
Dr ZinX Patent Pending
Dr ZinX Patent Pending Ingredient Combination: Zinc + Hinokitiol

Related Links

Dr ZinX Amazon Page

SOURCE Dr ZinX


These press releases may also interest you

at 03:35
Hecla Mining Company today announced second quarter 2020 financial and operating results. HIGHLIGHTS All mines in operation (non-U.S. mines had government-mandated shutdowns of less than a month). Sales of $166.4 million, an increase of 24%...

at 03:30
The "The Nanotechnology and Nanomaterials Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering. Nanotechnology and nanomaterials are key enablers for a whole new generation of products and processes. New products...

at 03:20
The "Industrial Thin-client Platform - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the global market for Industrial Thin-client Platform estimated at US$469.3 Million...

at 03:10
Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) will participate in the first virtual SEMICON Southeast Asia (SEMICON SEA) on August 11-21 as a sponsor, exhibiting its latest end-to-end IC test solutions and presenting...

at 03:05
PDI (www.pdisoftware.com), a global provider of ERP, fuel pricing, supply chain logistics, and marketing cloud solutions for the convenience retail and petroleum wholesale industries, announced the opening of its office in Hyderabad, India. The...

at 03:04
SQUARE ENIX HOLDINGS CO., LTD. (the "Company") today announced consolidated financial results for the three-month period ended June 30, 2020. The Company is listed on the First Section of the Tokyo Stock Exchange, with the stock code "9684," and...



News published on 1 august 2020 at 10:00 and distributed by: